Medications

Can aspirin help tackle some cancers?

Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest.

Oncology & Cancer

Hope for better lung cancer treatment on horizon

A Melbourne study is set to improve treatment options for patients with the second most common type of lung cancer, lung squamous cell carcinoma, a disease for which new anti-cancer drugs are urgently needed.

Medical research

Enzymatic danse macabre of lung cancer

A chromatin-regulating enzyme has been shown by in-depth interdisciplinary investigations to be a key driver of a common type of lung cancer. Drugs that target the enzyme could improve treatment and survival rates for this ...

Oncology & Cancer

Researchers identify genes responsible for lung tumors

The lung transcription factor Nkx2-1 is an important gene regulating lung formation and normal respiratory functions after birth. Alterations in the expression of this transcription factor can lead to diseases such as lung ...

Oncology & Cancer

New drugs, diagnostic approved for advanced melanoma

(HealthDay)—Two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved by the U.S. Food and Drug Administration to treat advanced melanoma, the most dangerous form of skin cancer.

Oncology & Cancer

New method for suppressing lung cancer oncogene

Researchers at Okayama University describe in Oncotarget an approach for suppressing the expression of the SOX2 protein, an oncogene associated with both lung and esophageal cancer. The procedure, based on the targeted delivery ...

page 4 from 6